Coffee Conversation: Hermantown Area Chamber Of Commerce President Talks Upcoming Events fox21online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox21online.com Daily Mail and Mail on Sunday newspapers.
EIP Pharma Announces Publication of Preclinical Results Demonstrating Potential of Neflamapimod to Promote Functional Recovery after Ischemic Stroke
Administration of neflamapimod during the subacute phase after transient ischemia induced stroke in rats promoted functional recovery
Associated increased levels of brain-derived neurotrophic factor (BDNF) suggest the effects were mediated by increasing synaptic plasticity
News provided by
Share this article
BOSTON, Dec. 16, 2020 /PRNewswire/
EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, announced today the scientific publication of preclinical results that demonstrate neflamapimod promotes functional recovery after ischemic stroke in rats. Entitled Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level, the report was published in the